Literature DB >> 16981180

Inhibition of CD1d1-mediated antigen presentation by the vaccinia virus B1R and H5R molecules.

Tonya J Roberts Webb1, Roberta A Litavecz, Masood A Khan, Wenjun Du, Jacquelyn Gervay-Hague, Gourapura J Renukaradhya, Randy R Brutkiewicz.   

Abstract

Vaccinia virus (VV) has been most commonly used as the vaccine to protect individuals against the causative agent of smallpox (variola virus), but it also uses a number of strategies meant to evade or blunt the host's antiviral immune response. Natural killer T (NKT) cells are a subset of immunoregulatory CD1d-restricted T lymphocytes believed to bridge the innate and adaptive immune responses. It is shown here that the VV-encoded molecules, B1R and H5R, play a role in the ability of VV to inhibit CD1d-mediated antigen presentation to NKT cells. These are the first poxvirus-encoded molecules identified that can play such a role in the evasion of an important component of the innate immune response.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16981180     DOI: 10.1002/eji.200636024

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  26 in total

Review 1.  Viral serine/threonine protein kinases.

Authors:  Thary Jacob; Céline Van den Broeke; Herman W Favoreel
Journal:  J Virol       Date:  2010-11-17       Impact factor: 5.103

Review 2.  Immune evasion of the CD1d/NKT cell axis.

Authors:  Randy R Brutkiewicz; Laura Yunes-Medina; Jianyun Liu
Journal:  Curr Opin Immunol       Date:  2018-05-04       Impact factor: 7.486

3.  Virus-encoded ectopic CD74 enhances poxvirus vaccine efficacy.

Authors:  Crystal C Walline; Sarah N Deffit; Nan Wang; Lynette M Guindon; Victoria L Crotzer; Jianyun Liu; Kristin Hollister; Laurence C Eisenlohr; Randy R Brutkiewicz; Mark H Kaplan; Janice S Blum
Journal:  Immunology       Date:  2014-04       Impact factor: 7.397

4.  Distinct requirements for activation of NKT and NK cells during viral infection.

Authors:  Aaron J Tyznik; Shilpi Verma; Qiao Wang; Mitchell Kronenberg; Chris A Benedict
Journal:  J Immunol       Date:  2014-03-14       Impact factor: 5.422

5.  JNK2 modulates the CD1d-dependent and -independent activation of iNKT cells.

Authors:  Jianyun Liu; Richard M Gallo; Masood A Khan; Abhirami K Iyer; Ian M Kratzke; Randy R Brutkiewicz
Journal:  Eur J Immunol       Date:  2018-12-03       Impact factor: 5.532

6.  Herpes simplex virus 1 glycoprotein B and US3 collaborate to inhibit CD1d antigen presentation and NKT cell function.

Authors:  Ping Rao; Hong Thanh Pham; Arpita Kulkarni; Yang Yang; Xueqiao Liu; David M Knipe; Peter Cresswell; Weiming Yuan
Journal:  J Virol       Date:  2011-06-08       Impact factor: 5.103

7.  Dietary fatty acids modulate antigen presentation to hepatic NKT cells in nonalcoholic fatty liver disease.

Authors:  Jing Hua; Xiong Ma; Tonya Webb; James J Potter; Mathias Oelke; Zhiping Li
Journal:  J Lipid Res       Date:  2010-02-24       Impact factor: 5.922

8.  Vesicular stomatitis virus matrix protein impairs CD1d-mediated antigen presentation through activation of the p38 MAPK pathway.

Authors:  Gourapura J Renukaradhya; Masood A Khan; Daniel Shaji; Randy R Brutkiewicz
Journal:  J Virol       Date:  2008-09-24       Impact factor: 5.103

9.  Vaccinia virus A35R inhibits MHC class II antigen presentation.

Authors:  Kristina E Rehm; Ramsey F Connor; Gwendolyn J B Jones; Kenneth Yimbu; Rachel L Roper
Journal:  Virology       Date:  2009-12-02       Impact factor: 3.616

10.  Direct CD1d-mediated stimulation of APC IL-12 production and protective immune response to virus infection in vivo.

Authors:  Simon C Yue; Michael Nowak; Angela Shaulov-Kask; RuoJie Wang; Dominic Yue; Steven P Balk; Mark A Exley
Journal:  J Immunol       Date:  2009-11-30       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.